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 Background- Two distinct morphologic types of colorectal 
cancer have been described in recent studies: polypoid growth 
type (PG-type) and nonpolypoid growth type (NPG-type). 
 Materials and Methods- We investigated possible biological 
and clinical differences between 37 PG-type and 156 NPG-
type cancers using both univariate and multivariate analy-
ses (logistic and Cox regression models). 
 Results- Unlike NPG-type cancers, PG-type cancers had a 
high proportion of well-differentiated adenocarcinoma cells, a 
high likelihood of being early colorectal cancers (carcinoma in 
situ and cancer invades submucosa), and a low frequency of 
lymph node metastasis. On average, such PG-type cancers also 
carried a better prognosis than NPG-type cancers (P=0.01). In 
particular, PG-type cancer patients with stage IV tumors had 
a better prognosis than NPG-type cancer patients (P=0.02). 
In fact, after performing a Cox regression analysis, we found 
that colorectal cancer growth type is an independent prog-
nostic variable, separate from histologic type or stage. 
 Conclusions- PG-type colorectal cancer is less aggressive and 
has a favorable prognosis compared to NPG-type cancer.
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Introduction
 Colorectal cancer, much like other cancers, has a 
prognosis that depends significantly upon the staging
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of the tumor at the time of diagnosis and treatment. 
Fortunately, recent advances in endoscopical technol-
ogy for colorectal tumors have allowed for the detec-
tion of increasing numbers of small, early colorectal 
cancers (tumors in which invasion is limited to but no 
deeper than the submucosa)'>. The utilization of such 
new technology has brought an enhanced understand-
ing of the underlying disease process. Specifically, care-
ful investigation of early colorectal cancers, which were 
resected endoscopically or surgically, has revealed two 
different morphological types and suggested the exis-
tence of alternative biological and molecular pathways 
leading to the development of colorectal cancers. 
 Pathological distinctions further underscore the no-
tion of two tumor growth patterns, as flat-type early 
colorectal cancer both appears and behaves differently 
than polypoid early cancers',". Namely, such flat-type 
early cancers have a low incidence of accompanying 
adenomas and often invade the submucosal layer when 
they are small in size',". In contrast, pedunculated or 
sessile polypoid growth, which is seen in the majority of 
early cancers, demonstrate carcinoma within adenomatous 
tissue by histology','). Based upon these observations, 
some researchers postulate that polypoid early cancers 
may originate from protruding adenomas, whereas flat 
type early cancers may develop de novos'> or from flat 
adenomas". 
 Shimoda et al.") classifies colorectal cancers into two 
types based upon growth patterns: polypoid growth (PG-
type) and nonpolypoid growth (NPG-type) cancers. The 
gross and histologic growth patterns seen in NPG-type 
early cancers are identical to those seen in NPG-type ad-
vanced cancers (tumors in which invasion extended into 
the muscularis propria and deeper tissues)"). In keeping 
with such findings, NPG-type early cancers have received 
increasingly greater attention as a likely precursor
candidate for advanced colorectal cancer. Recently, fur-
ther evidence for the legitimacy of Shimoda s classifica-
tion system has come as studies have described differ-
ences in the cellular and genetic features of PG-type 
and NPG-type cancers, as determined by molecular 
analyses. The cellular and genetic differences include 
differing incidences of K-ras mutation"""', cellular pro-
liferation activities"), and distinct chromosomal aberra-
tions","). 
 Collectively, these observations suggest that separate 
genetic pathways for tumor progression may exist for 
PG-type and NPG-type colorectal cancers. Despite the 
advancements in research and understanding, the bio-
logically and clinically relevant differences between 
the two tumor morphologies has yet to be fully eluci-
dated. Even in the report of Shimoda et al.10', it was 
not enough to discuss the relationship between the 
clinicopathological factors or patient prognosis and the 
tumor growth patterns, ie. PG-type and NPG-type. We 
hypothesize that such morphologic differences between 
PG-type and NPG-type cancers may reflect underlying 
differences in biological characteristics as well as in the 
cellular or genetic features of the cancer cells them-
selves. Therefore, the present study was designed to 
clarify the different biological characteristics possessed 
by PG-type and NPG-type colorectal cancers, as as-
sessed by clinicopathological variables using univariate 
and multivariate analysis.
tions, including laboratory testing every 3 months. 
Chest roentgenogram, computed tomography, abdomi-
nal ultrasound scanning, and colonoscopy were per-
formed annually. The median length duration of follow-
up time was 1827 days (range: 108 - 3861 days). Of 
the 193 patients, 118 patients are alive at the time of 
this writing (July, 1999). Recurrence of colorectal can-
cer followed by death occurred in 59 patients, and 16 
patients died of a different disease with no evidence of 
colorectal tumor. The data on patients who died of 
causes other than colorectal cancer were censored in 
the statistical analysis").
Tumor growth pattern
 According to Shimoda s classification10', all tumors 
were classified into two groups based on morphologic 
pattern of tumor growth as follows: (1) polypoid 
growth type (PG-type) cancer is characterized by an 
exophytic growth pattern and a mucous membrane 
immediately adjacent to the edge of the colorectal car-
cinoma tissue is covered by everted carcinoma tissue 
(Fig. 1), and (2) nonpolypoid growth type (NPG-type ) 
cancer primarily is characterized by massive invasion 
into the deeper tissue and a mucous membrane imme-
Materials and Methods
 A total of 193 patients with primary colorectal cancers 
who underwent surgical resection at Nagasaki University 
Hospital between January 1986 and December 1993 were 
studied. The exclusion criteria for this study were the 
following: more than one cancer of the colon and rec-
tum, polyposis coli, a tumor which directly invades 
other organs or structures and/or perforates visceral 
peritoneum, or macroscopic-type cancers such as dif-
fusely infiltrating and unclassified types. American Joint 
Committee on Cancer Classification and Stage group-
ings were used for tumor assessment"'. All colorectal 
carcinoma specimens were fixed in formalin, embedded 
in paraffin, and stained with hematoxylin and eosin. 
After staining, histologic types were determined by two 
pathologists according to the World Health Organization 
International Histological Classification of Tumours"'. 
Additionally, all routine slides were carefully screened 
to identify venous and lymphatic invasion when tumor 
tissue was seen within vein and lymph-vessel, respec-
tively. 
 All patients underwent standard follow-up examina-
Figure 1. Microscopic profile of PG-type colorectal cancer 
(Hematoxylin and eosin; x1.0).
Figure 2. Microscopic profile of NPG-type colorectal cancer 
(Hematoxylin and eosin; x1.0).
diately adjacent to the edge of carcinoma tissue is free 
of carcinoma tissue (Fig. 2).
Statistical analysis
 Statistical analyses were performed using SAS 
statistical-analysis software (SAS Institute, Cary, North 
Carolina, USA). Specifically, univariate analyses were 
conducted as follows: categorical data were analyzed 
by chi-square or Fisher's exact probability tests; con-
tinuous data were analyzed using the unpaired t-test; 
survival analyses were performed using the Kaplan-
Meier method 201, and differences between the curves were 
tested using the log-rank test21'. 
 In order to conduct multivariate analyses, we em-
ployed both the logistic regression model22,23) and the 
Cox proportional hazards model"'. The logistic regres-
sion analysis was chosen to study the predictive value 
of risk factors because the outcome variable was bi-
nary, such as NPG-type vs. PG-type 211 . By means of 
univariate analysis, potentially predictive variables 
were identified at a significance level of P < 0.25, and 
these variables were then used for logistic regression 
multivariate anal ysis22'. The odds were expressed as 
the ratio of NPG-type to that of PG-type for a given 
value of an independent variable. Factors related to 
survival were also analyzed with the Cox proportional 
hazards regression model"). The tumor growth pat-
terns (PG-type and NPG-type) were compared to other 
prognostic variables, including stage and histologic type 
that are generally used in ' colorectal cancer patient 
management and well-supported in the literature"). All 
tests were two-tailed and a P value of less than 0.05 
was considered significant.
Results
 Of the 193 colorectal cancers, 37 (19.2%) were clas-
sified as PG-type cancers and 156 (80.8%) were classi-
fied as NPG-type cancers.
Comparison of the clinicopathologic features of the 
PG-type and the NPG-type cancers 
 There were no differences in age, sex, tumor loca-
tion, tumor size, M factor, lymphatic involvement, or 
venous involvement between the PG-type and the NPG-
type cancers (Table 1). However, in contrast to NPG-
type cancer, PG-type cancer had a high proportion of 
well-differentiated adenocarcinoma cells, a high ratio of 
Tis/T1 tumors (P=0.001 and P=0.001, respectively),
Table 1. Clinicopathological features of colorectal cancers ac-
cording to tumor growth patterns.
                                    No. of Cancers (%) 
Variable PG-type NPG-type P value 
                                         cancer' cancer' 
                             (n=37) (n=156) 
Age b (years) 65.3.t 10.5 62.4.t 11.7 0.17 
Sex 0.71 
  Male 21 (56.8) 94 (60.3) 
  Female 16 (43.2) 62 (39.7) 
Tumor location 0.45 
  Colon 24 (64.9) 88 (56.4) 
  Rectum 13 (35.1) 68 (43.6) 
Tumor size b (cm) 5.2 ± 2.1 5.0 -± 1.8 0.52 
Histologic type 0.001 
  Well differentiated 20 (54.1) 33 (21.1) 
  Moderately differentiated 13 (35.1) 112(71.8) 
  Poorly differentiated/ Mucinous 4(10.8) 11(7.1) 
T 0.001 
  Tis/T1 10 (27.0) 3(1.9) 
  T2 4(10.8) 16 (10.3) 
  T3 23 (62.2) 137(87-8) 
N 0.002 
  NO 29 (78.4) 79 (50.6) 
  N1/N2 8(21.6) 77 (49.4) 
M 0.75 
  MO 33 (89.2) 142 (91.0) 
  M1 4(10.8) 14(9.0) 
Lymphatic involvement 0.40 
  Absent 11 (29.7) 36 (23.1) 
  Present 26 (70.3) 120(76-9) 
Venous involvement 0.66 
  Absent 30 (81.1) 118 (75.6) 
  Present 7(18.9) 38 (24.4) 
Stage 0.001 
  I 12 (32.4) 12(7.7) 
  II 15 (40.5) 66(42.3) 
  III 6(16.2) 64 (41.0) 
  IV 4(10.8) 14(9.0)
' PG
, Polypoid growth; NPG, Nonpolypoid growth. 
b Age and tumor size were expressed as mean values -t standard deviations
.
and a low frequency of lymph node metastasis (P 
=0 .002). PG-type cancers were also, on average, at a less 
advanced stage than the NPG-type cancers (P=0.001).
Patient survival and tumor growth patterns, NPG-
versus-PG-type 
 Among the patients included in this study, there 
was a significant difference between the survival of 
those with PG-type and NPG-type cancers, in that PG-
type cancer patients had a better prognosis (P=0.01). 
In the patients with stage I/I1 or III tumors, there was 
no difference in the survival between PG-type and NPG-
type cancer, although PG-type cancer patients with stage 
IV tumors had a better prognosis than NPG-type can-
cer patients (P=0.02) (Fig. 3). Of four PG-type cancer 
patients with stage IV tumors, three patients (whose tu-
mors were T3NOM 1, T3NOM 1, and T3N 1 M 1) who un-
derwent surgical resection for both primary colorectal 
tumors and synchronous liver or lung metastases, had 
a long duration of survival after surgery (2026, 2126, 
and 2018 days). However, one patient (T3N2M1) who 
had unresectable metastases in the liver, adrenal gland, 
and lung, died at 557 days after surgery.
curative resection, 6 patients developed tumor recur-
rence after surgery, of which 5 (5/6, 83.3%) were 
hematogenous metastases and 1 was a local recurrence 
within the pelvis. Of the 138 NPG type-cancer patients 
who underwent curative resections, 40 patients devel-
oped tumor recurrence after surgery. Of these 40 cases, 
19 (19/40, 47.5%) were hematogenous metastases, 14 
were local/lymph node recurrences, 4 were peritoneal 
disseminations, and 4 were unknown recurrences (one 
patient developed both liver and peritoneal metasta-
sis). A ratio of hematogenous metastases to tumor 
recurrences after curative surgery in PG-type cancer 
patients was higher that that in NPG-type cancer pa-
tients, although the difference was not significant 
(83.3% vs 47.5%, respectively, P=0.18).
Predictive value of tumor growth patterns, NPG-versus-
PG-type 
 In order to determine the independent factors that 
were related to tumor growth patterns for colorectal 
cancer (i.e. NPG-versus-PG-type), logistic regression 
analysis was conducted. Four factors (age, histologic 
type, T, N), which were identified at a significance 
level of P<0.25 by means of univariate analysis 
(Table 1), were included in this analysis. Of these 
studied factors, three variables -- namely histologic, T 
factor and N factor -- were found to be independently 
related to tumor growth patterns (Table 2). That is, 
NPG-type cancer was characterized by a high propor-
tion of moderately-differentiated adenocarcinoma cells, 
a high proportion of T2 and T3 tumors, and a high
Table 2. Results of multivariate analysis using the logistic re-
gression model for tumor growth pattern of colorectal cancer.
Figure 3. Survival curves for two groups of patients with 
PG-type and NPG-type colorectal cancer. Among all of the pa-
tients studied, there was a significant difference between the 
survivals of PG-type and NPG-type cancer patients, in that 
PG-type cancer patients had a better prognosis (P=0.01). In 
the patients with stage I/II or III tumors, there was no differ-
ence in the survival between PG-type and NPG-type cancer, 
although PG-type cancer patients with stage IV tumors had 
a better prognosis than NPG-type cancer patients (P=0.02).
Comparison of patterns of initial recurrence after 
curative surgery between two tumor growth patterns, 
NPG-versus-PG-type 
 Of the 34 PG-type cancer patients who underwent
Variable Odds ratio (95% Confidence interval) 
Age 
   z63 years 1.00 
  <63 years 1.82 (0.76-4.35) 
Histologic type 
  Well differentiated 1.00 
  Moderately differentiated 3.06 (1.20-7.82) 
  Poorly differentiated/ Mucinous 0.85 (0.20-3.59) 
T 
  Tis/T1 1.00 
  T2 10.86 (1.68-70.01) 
  T3 12.83 (2.71-60.72) 
N 
  NO 1.00 
  N 1/N2 3.46 (1.32-9.06)
frequency of lymph node metastasis (odds ratio = 3.06, 
10.86, 12.83, and 3.46, respectively).
Prognostic value of tumor growth patterns, NPG-
versus-PG-type 
 In order to clarify the independent predictive value 
of each clinicopathological variable for survival after 
surgery, Cox's regression analysis was performed. In 
this case, three factors (tumor growth pattern, histologic 
type, stage) were included. The tumor growth pattern 
(i.e. NPG-type or PG-type) proved to be independently 
associated with patient survival following surgery, sepa-
rate from histologic type or stage. That is, the patients 
who had NPG-type cancer had a worse survival out-
come compared with patients who had PG-type cancer 
(hazard ratio = 3.13) (Table 3).
Table 3. Results of multivariate analysis using Cox's propor-
tional hazard regression model.
Variable Hazard ratio (95% Confidence interval) 
Tumor growth pattern 
   PG-type' 1.00 
   NPG-type' 3.13 (1.25-7.83) 
Histologic type 
  Well differentiated 1.00 
  Moderately differentiated 1.14 (0.59-2.21) 
  Poorly differentiated/ Mucinous 3.25 (1.20-8.77) 
Stage 
  I/II 1.00 
  III 3.80 (2.02-7.13) 
  IV 19.12 (8.54-42.78)
'PG
, Polypoid growth; NPG, Nonpolypoid growth.
Discussion
 We previously reported the differential expression of 
sialyl Tn antigen between polypoid and flat-type early 
colorectal cancers"). Sialyl Tn is a tumor-specific car-
bohydrate antigen which is strongly expressed in a 
large number of colorectal cancers, while it is not ex-
pressed at all in normal mucosa26'. This antigen might 
be useful as an intermediate end point biomaker of 
transformation from normal epithelium to adenomas 
with a potential for malignancy"'. Specifically, Sialyl 
Tn antigen was expressed in 17 (54.9%) of 31 polypoid 
early cancers and 4 (14.9%) of 27 flat-type early can-
cers, and this difference was statistically significant25'. 
Although the microscopic features of these cancers 
were similar, such characteristics of the cancer cells
themselves in polypoid and flat-type early cancers were 
different"). Distinct cellular or genetic features defined 
by molecular analysis with respect to the growth pattern 
classification involving PG-type and NPG-type cancers 
have been reported. Compared to PG-type cancers, NPG-
type cancers possess a low incidence of K-ras mutation 
s9• different cellular proliferation activity"', and dif-
ferent numerical chromosomal aberrations","). Based 
upon these reports, there may be at least two different 
pathways in colorectal carcinogenesis and tumor pro-
gression, and it may be important to recognize the ex-
istence of a NPG-type cancer pathway that is quite dif-
ferent from the PG-type cancer pathways'. 
 Besides the potential clinical, cellular, and molecular 
reasons for distinction among PG-type and NPG-type 
cancers, biological features supply an added basis for 
separation. The current study reveals that NPG-type can-
cer have a higher proportion of moderately-differentiated 
adenocarcinoma cells, a higher ratio of T2/T3 tumors, 
and a higher frequency of lymph node metastasis than 
PG-type cancers, as shown by univariate and multivariate 
(logistic regression) analyses. Yanagida et al.'s work"' 
provides more evidence elucidating the fundamental 
differences between the two growth patterns as he 
demonstrates that NPG-type cancers are smaller in 
size, found in younger age, and more commonly have 
lymph node metastasis than PG-type cancers. Shimoda 
et al."' also reported that lymphatic and venous per-
meation in NPG-type early cancers was detected more 
often than in PG-type cancers. Although NPG-type can-
cers are smaller than those of PG-type, marked 
submucosal invasion, lymphatic spread, and venous per-
meation of cancer cells were observed in NPG-type can-
cers1°'. Collectively, these data suggest that many NPG-
type cancers may exhibit tumor aggressiveness not 
seen in most PG-type cancers - a behavior that may 
explain their poorer outcomes. In our study, the ob-
tained data did reinforce this idea, as a significant dif-
ference between the survival of PG-type and NPG-type 
cancer patients was evident, with NPG-type cancer pa-
tients having a poorer prognosis. Furthermore, the 
multivariate analysis using Cox regression analysis 
proved that tumor growth pattern (i.e. NPG-type or 
PG-type) is an independent prognostic variable, in ad-
dition to and separate from histologic type and stage. 
 Within our study group, PG-type colorectal cancer 
represented 19.2% of the 193 cancers studied, compris-
ing 77.0% of 13 early colorectal cancers and 15.0% of 
180 advanced cancers. Shimoda et al."' also reported 
the similar incidence of PG-type cancer. Why is there 
a difference in the proportion of PG-type cancer be-
tween the early and advanced colorectal cancer? There 
is an idea that NPG-type early cancer may be the
major precursor for advanced colorectal cancer, while 
PG-type early cancer, possessing less tumor. aggressive-
ness and slower progression, may be the minor precur-
sor candidate for advanced cancer"'. On the other 
hand, Matsui et al."' recently reported that, to some 
extent, PG-type early colorectal cancer develops into 
NPG-type advanced cancer, based on a retrospective 
analysis of barium enema studies. It is speculated that 
some of the PG-type early cancers may develop mor-
phologically into NPG-type advanced cancers. This 
phenomenon may be associated with necrosis and de-
struction of the polypoid-type cancer tissues correlat-
ing with increased malignant behavior, such as ad-
vanced invasion or deterioration of histologic 
differentiation. 
 Thus, it remains unclear which growth type of early 
colorectal cancer may be the major precursor of ad-
vanced colorectal cancer. However, in the current study, 
at least two distinct growth patterns (PG-type or NPG-
type) are characterized by biological and clinical fea-
tures. In contrast to the NPG-type cancers, the PG-type 
cancers seem to be characterized by less tumor aggres-
siveness and a favorable prognosis. In addition, tumor 
growth pattern is not correlated with the presence or 
absence of distant metastasis (M factor). The PG-type 
cancers with synchronous hematogenous metastases 
(liver or lung), which are concurrently resected with 
the primary tumors, seem to have a favorable progno-
sis. Furthermore, it seems that the PG-type cancer has 
a tendency to develop hematogenous metastases after 
curative surgery, compared to the NPG-type cancer. 
Based upon these findings, we think that an aggres-
sive surgical resection for the hematogenous metasta-
ses from the PG-type cancer, which has a high propor-
tion of well-differentiated cells and a low frequency of 
lymph node metastasis, may ' be recommended. 
 On the other hand, the NPG-type cancers seem to be 
characterized by more tumor aggressiveness and a 
worse prognosis. The detection for early-staged NPG-
type cancers, as well as early-staged PG-type cancers, 
is essential for curing colorectal cancer. Therefore, we 
feel that increased screening must be performed in 
order to detect early-staged NPG-type cancers, in rec-
ognition of the fact that such NPG-type cancers may 
be often overlooked by means of colonoscopy or a bar-
ium enema study, given that NPG-type early cancers 
are generally small and have flat-typed shapes2,'o>.
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